Premier Path Wealth Partners LLC Has $306,000 Stock Position in Agilent Technologies, Inc. (NYSE:A)

Premier Path Wealth Partners LLC lifted its position in shares of Agilent Technologies, Inc. (NYSE:AFree Report) by 4.8% during the 4th quarter, Holdings Channel.com reports. The firm owned 2,276 shares of the medical research company’s stock after purchasing an additional 105 shares during the quarter. Premier Path Wealth Partners LLC’s holdings in Agilent Technologies were worth $306,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Livelsberger Financial Advisory bought a new stake in shares of Agilent Technologies in the 3rd quarter valued at approximately $28,000. Ashton Thomas Securities LLC bought a new stake in Agilent Technologies in the third quarter valued at $31,000. Fortitude Family Office LLC grew its position in Agilent Technologies by 68.3% in the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock valued at $35,000 after acquiring an additional 95 shares during the period. RPg Family Wealth Advisory LLC bought a new position in shares of Agilent Technologies during the third quarter valued at $38,000. Finally, Retirement Wealth Solutions LLC bought a new position in shares of Agilent Technologies during the fourth quarter valued at $46,000.

Agilent Technologies Stock Performance

Agilent Technologies stock opened at $147.57 on Friday. The company has a market cap of $42.15 billion, a PE ratio of 33.39, a PEG ratio of 3.71 and a beta of 1.06. The company has a current ratio of 2.09, a quick ratio of 1.58 and a debt-to-equity ratio of 0.57. Agilent Technologies, Inc. has a 1 year low of $124.16 and a 1 year high of $155.35. The company’s 50-day moving average is $136.48 and its two-hundred day moving average is $137.19.

Agilent Technologies (NYSE:AGet Free Report) last posted its quarterly earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.05. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The business had revenue of $1.70 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same period in the previous year, the firm posted $1.38 earnings per share. Agilent Technologies’s revenue for the quarter was up .8% compared to the same quarter last year. Equities analysts anticipate that Agilent Technologies, Inc. will post 5.56 earnings per share for the current year.

Agilent Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st will be paid a dividend of $0.248 per share. The ex-dividend date is Tuesday, December 31st. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.67%. Agilent Technologies’s payout ratio is 22.40%.

Analysts Set New Price Targets

A has been the subject of a number of recent analyst reports. Bank of America dropped their target price on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a research report on Friday, December 13th. Wells Fargo & Company dropped their price objective on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a report on Monday, December 9th. Sanford C. Bernstein reduced their target price on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a report on Tuesday, November 26th. JPMorgan Chase & Co. dropped their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday, November 26th. Finally, Citigroup boosted their price objective on Agilent Technologies to $165.00 and gave the stock a “buy” rating in a research note on Thursday, December 19th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $143.62.

Read Our Latest Report on Agilent Technologies

Agilent Technologies Profile

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Featured Stories

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.